Starling Oncology (STLN) Stock Price, Quote, News & History

SPY772.04 QQQ745.40 BTC/USD82,899.93−1.83%DIA517.72 GLD393.05 TLT79.38

Starling Oncology Inc (STLN) Stock Price, Quote, News & History

STLNNASDAQ

Trade with Public

$6.66

At close: Sep 28, 5:00 PM EST

$6.80

0.142.1%

After Hours: Sep 25, 5:14 PM EST

OverviewNews Earnings Forecast Events Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

Volume / Avg.

0 / 1.49M

Day Range

- - -

52 Wk Range

4.85 - 7.13

Market Cap

$679.88M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

8.05%

Days to Cover

7.35

Recent Starling Oncology, Inc. News

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Aardvark Therapeutics (NASDAQ:AARD) shares increased by 8.5% to $6.28 during Friday's after-market session. The market value of their outstanding shares is at $144.8 million. TransCode Therapeutics

Benzinga Insights

PRO
Starling Oncology shares are trading higher after the company reported a year-over-year decrease in Q2 loss per share and increase in sales results.

Benzinga Newsdesk

PRO
Starling Oncology Q2 EPS $(0.08) Up From $(0.15) YoY, Sales $161.282M Up From $119.802M YoY

Starling Oncology (NASDAQ:STLN) reported quarterly losses of $(0.08) per share. This is a 46.67 percent increase over losses of $(0.15) per share from the same period last year. The company reported $161.282 million in

Benzinga Newsdesk

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out yesterday.

Benzinga Insights

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The market value of their outstanding shares is at $3.7 billion. As per the news, the Q1 earnings report came out

Benzinga Insights

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

328.00K

Investing Cash Flow (TTM)

-3.61M

Financing Cash Flow (TTM)

14.09M

Free Cash Flow (TTM)

-3.29M

Capital Expenditure (TTM)

-3.61M

Net Change in Cash (TTM)

10.80M

Valuation Metrics

Enterprise Value

$742.14M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

1.15

PB Ratio (TTM)

Earnings Yield % (TTM)

-4.35%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.24

Company Debt

Total Debt

$79.87M

LT Debt

$79.87M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$34.00K

Total Cash

$41.09M

Debt to Equity

Issuance of Debt (TTM)

-$34.00K

Repayment of Debt (TTM)

-$34.00K

Key Statistics

Open

Volume / Avg.

0 / 1.49M

Day Range

- - -

52 Wk Range

4.85 - 7.13

Market Cap

$679.88M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

8.05%

Days to Cover

7.35

About

Sector

Health Care

Industry

Health Care Providers & Services

Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy Starling Oncology (STLN) stock?

You can purchase shares of Starling Oncology (NASDAQ:STLN) through any online brokerage.

View our list of the best stock brokerages

Who are Starling Oncology (STLN) competitors?

Other companies in Starling Oncology’s space includes: HCA Healthcare Inc (NYSE:HCA), Tenet Healthcare Corp (NYSE:THC), Encompass Health Corp (NYSE:EHC), Universal Health Services Inc (NYSE:UHS) and Ensign Group Inc (NASDAQ:ENSG).

What is the forecast, or price target, for Starling Oncology (STLN) stock?

There is no analysis for Starling Oncology to provide a consensus price target.

What is the current price for Starling Oncology (STLN)?

The stock price for Starling Oncology (NASDAQ: STLN) is $6.8 last updated September 25, 2026 at 5:14 PM EDT.

Does Starling Oncology (STLN) pay a dividend?

There are no upcoming dividends for Starling Oncology.

When is Starling Oncology (NASDAQ:STLN) reporting earnings?

Starling Oncology does not have any upcoming earnings scheduled.

Is Starling Oncology (STLN) going to split?

There is no upcoming split for Starling Oncology.

What sector and industry does Starling Oncology (STLN) operate in?

Starling Oncology is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Starling Oncology Inc (STLN) Stock Price, Quote, News & History

Starling Oncology (STLN) Stock Price, Quote, News & History | Benzinga

Key Statistics

Recent Starling Oncology, Inc. News

12 Health Care Stocks Moving In Friday's After-Market Session

PROStarling Oncology shares are trading higher after the company reported a year-over-year decrease in Q2 loss per share and increase in sales results.

PROStarling Oncology Q2 EPS $(0.08) Up From $(0.15) YoY, Sales $161.282M Up From $119.802M YoY

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Financials

Cash Flows

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

FAQ

How do I buy Starling Oncology (STLN) stock?

Who are Starling Oncology (STLN) competitors?

What is the forecast, or price target, for Starling Oncology (STLN) stock?

What is the current price for Starling Oncology (STLN)?

Does Starling Oncology (STLN) pay a dividend?

When is Starling Oncology (NASDAQ:STLN) reporting earnings?

Is Starling Oncology (STLN) going to split?

What sector and industry does Starling Oncology (STLN) operate in?

PRO
Starling Oncology shares are trading higher after the company reported a year-over-year decrease in Q2 loss per share and increase in sales results.

PRO
Starling Oncology Q2 EPS $(0.08) Up From $(0.15) YoY, Sales $161.282M Up From $119.802M YoY